SNP-Based Analysis of Genetic Substructure in the German PopulationSteffens M.a · Lamina C.b · Illig T.b · Bettecken T.d · Vogler R.e · Entz P.f · Suk E.-K.f · Toliat M.R.f · Klopp N.b · Caliebe A.g · König I.R.h · Köhler K.i · Lüdemann J.j · Diaz Lacava A.a · Fimmers R.a · Lichtner P.d · Ziegler A.h · Wolf A.g · Krawczak M.g · Nürnberg P.f · Hampe J.e · Schreiber S.e · Meitinger T.c, d · Wichmann H.-E.b · Roeder K.k · Wienker T.F.a · Baur M.P.a
aInstitute of Medical Biometry, Informatics and Epidemiology, Rheinische Friedrich-Wilhelms-University, Bonn, bInstitute of Epidemiology, GSF National Research Center, Munich-Neuherberg, cInstitute of Human Genetics, Technical University Munich, Munich, dInstitute of Human Genetics, GSF National Research Center, Munich-Neuherberg, eDepartment of General Internal Medicine, Christian-Albrechts-University, Kiel, fGene Mapping Center at the Max-Delbrück-Center, Berlin, gInstitute of Medical Statistics and Informatics, Christian-Albrechts-University, Kiel, hInstitute of Medical Biometry and Statistics, University of Lübeck, Lübeck, iDepartment of Genetic Epidemiology, University of Göttingen, Göttingen, jInstitute of Clinical Chemistry and Laboratory Medicine, University of Greifswald, Greifswald, Germany; kDepartment of Statistics, Carnegie Mellon University, Pittsburgh, Pa., USA
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Objective: To evaluate the relevance and necessity to account for the effects of population substructure on association studies under a case-control design in central Europe, we analysed three samples drawn from different geographic areas of Germany. Two of the three samples, POPGEN (n = 720) and SHIP (n = 709), are from north and north-east Germany, respectively, and one sample, KORA (n = 730), is from southern Germany. Methods: Population genetic differentiation was measured by classical F-statistics for different marker sets, either consisting of genome-wide selected coding SNPs located in functional genes, or consisting of selectively neutral SNPs from ‘genomic deserts’. Quantitative estimates of the degree of stratification were performed comparing the genomic control approach [Devlin B, Roeder K: Biometrics 1999;55:997–1004], structured association [Pritchard JK, Stephens M, Donnelly P: Genetics 2000;155:945–959] and sophisticated methods like random forests [Breiman L: Machine Learning 2001;45:5–32]. Results: F-statistics showed that there exists a low genetic differentiation between the samples along a north-south gradient within Germany (FST(KORA/POPGEN): 1.7 · 10–4; FST(KORA/SHIP): 5.4 · 10–4; FST(POPGEN/SHIP): –1.3 · 10–5). Conclusion: Although the FST -values are very small, indicating a minor degree of population structure, and are too low to be detectable from methods without using prior information of subpopulation membership, such as STRUCTURE [Pritchard JK, Stephens M, Donnelly P: Genetics 2000;155:945–959], they may be a possible source for confounding due to population stratification.
© 2006 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.